Lyssn vs Verbal (2026)
Both listen to conversations that clinicians are having and judge them, and they judge different things. Lyssn measures the quality of psychotherapy, estimating fidelity to the therapeutic method a programme is supposed to be delivering, which addresses a real and well documented problem: health systems fund evidence based therapy and have almost no way to know whether it is being delivered. Verbal audits interactions for compliance, sitting beside existing telephony, logging every call and routing findings to compliance teams rather than to supervisors. Lyssn is the stronger record by a distance, with its method published in peer reviewed literature and independent academic evidence behind it. Both raise the same uncomfortable question a buyer should settle first: these recordings measure individual clinicians, and a finding can follow a person into a performance review.
- It measures psychotherapy quality itself, estimating fidelity to the therapeutic method, which is a fundamentally different job from documenting or auditing a conversation.
- The transparency position is the strongest in behavioral health and among the best in this index, with the method published in peer reviewed literature rather than described in marketing.
- The evidence is genuinely independent and academically produced, in a category where almost everything is vendor generated.
- It audits every interaction for compliance rather than sampling, sitting alongside existing telephony and logging calls, which is a different and broader surveillance surface.
- Findings route to compliance teams rather than to clinicians, so it is a governance tool rather than a supervision one.
- It applies one function across many contexts, including customer types nothing else in this index serves.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Lyssn and Verbal are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Lyssn | Verbal |
|---|---|---|
| Primary category | Behavioral Health AI | Healthcare Administrative Automation |
| Founded | Not recorded | 2024 |
| Headquarters | Seattle, Washington, United States | Not recorded |
| Website | lyssn.io | tryverbal.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Lyssn its top capability grade on AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Set against Verbal, Lyssn grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Clinical and Operational Evidence. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Verbal its top capability grade on AI Centrality. Set against Lyssn, Verbal does not grade higher on any scored axis, though the two are level on several axes, including AI Centrality, Model Supply Chain Disclosure and FDA and Regulatory Status. Its thinnest published disclosure sits on Security Certifications and Trust Center and Commercial Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Lyssn or Verbal?
The AI Health Index grades Lyssn higher than Verbal on every axis that separates them, several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Clinical and Operational Evidence. Verbal does not grade higher on any scored axis.
Where do Lyssn and Verbal differ most?
The widest separation the AI Health Index records between Lyssn and Verbal is on Model and Technology Transparency, where Lyssn grades A and Verbal grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Lyssn and Verbal grade the same?
The AI Health Index grades Lyssn and Verbal the same on several axes, including AI Centrality, Model Supply Chain Disclosure and FDA and Regulatory Status. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Lyssn and Verbal not disclosed?
At the last review, at least one of Lyssn and Verbal published thin or absent detail on Security Certifications and Trust Center and Commercial Transparency. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Workforce & Training page.
Both products analyse recorded conversations between staff and patients, which creates a workforce monitoring exposure that neither fully addresses: the same recording that measures therapeutic fidelity or compliance also documents an individual clinician's performance, and a substantiated finding can affect employment or licensure. Establish what the clinician is told, who can see individual level results, and whether findings can be aggregated to the person.
Verbal publishes no security attestation of any kind and no pricing. Lyssn publishes no pricing basis. Neither publishes performance by clinician accent or dialect, which would bias any quality measurement against clinicians who do not sound like the training data.